Unlock your academic potential and expand your network by joining us!

Nasim Sanadgol

Mrs. Nasim Sanadgol

PhD candidate at the University of Vienna, Department of Pharmaceutical Chemistr...

Share Link

Share

Information

Nasim Sanadgol studied Pharmacy at the Mashhad University of Medical Sciences. In 2013 she obtained her Pharm.D. degree in Pharmacy at the Department of Pharmaceutics. She worked on the development of a microscale controlled-release drug delivery system based on bio-compatible and bio-degradable polymers for cationic agents as her thesis. She is continuing her study in pharmacy at the University of Vienna since 2018. As she was a part of a neuroscience/proteomics lab at the first year of her PhD study, She is experienced in practical techniques such as normal and primary cell culture, western blotting, Immunoprecipitation, and animal behavior paradigms. based on her greatest scientific interest, In May 2019 Nasim Sanadgol joined the Department of Pharmaceutical Chemistry at the University of Vienna for the design and development of targeted drug delivery systems based on molecular imprinting technology toward cancer therapy.

Research Keywords & Expertise

cancer therapy
Drug delivery system
Molecular and Cell Bio...
nanoparticals
Molecularly imprinted ...

Short Biography

Nasim Sanadgol studied Pharmacy at the Mashhad University of Medical Sciences. In 2013 she obtained her Pharm.D. degree in Pharmacy at the Department of Pharmaceutics. She worked on the development of a microscale controlled-release drug delivery system based on bio-compatible and bio-degradable polymers for cationic agents as her thesis. She is continuing her study in pharmacy at the University of Vienna since 2018. As she was a part of a neuroscience/proteomics lab at the first year of her PhD study, She is experienced in practical techniques such as normal and primary cell culture, western blotting, Immunoprecipitation, and animal behavior paradigms. based on her greatest scientific interest, In May 2019 Nasim Sanadgol joined the Department of Pharmaceutical Chemistry at the University of Vienna for the design and development of targeted drug delivery systems based on molecular imprinting technology toward cancer therapy.